Nevro Corp
NYSE:NVRO

  • LAST PRICE
    9.0300
  • TODAY'S CHANGE (%)
    -0.2200 (-2.3784%)
  • Bid / Lots
    8.6800/ 1
  • Ask / Lots
    9.6000/ 1
  • Open / Previous Close
    9.0900 / 9.2500
  • Day Range
    8.9850
    9.3450
  • 52 Week Range
    8.9300
    26.6300
  • Volume
    691,594

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Jun 11, 2024

      Show headlines and story abstract

    • 4:15PM ET on Tuesday Jun 11, 2024 by PR Newswire
      Companies Mentioned: NVRO

      Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that members of its management team will participate in a "fireside chat" (question-and-answer) session at the Truist Securities MedTech Conference on Tuesday, June 18, 2024, beginning at approximately 8:40 am EDT.

    • 4:15PM ET on Tuesday Jun 11, 2024 by Dow Jones
      Companies Mentioned: NVRO

      Nevro to Present at Truist Securities MedTech Conference

      PR Newswire

      REDWOOD CITY, Calif., June 11, 2024

      REDWOOD CITY, Calif., June 11, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that members of its management team will participate in a "fireside chat" (question-and-answer) session at the Truist Securities MedTech Conference on Tuesday, June 18, 2024, beginning at approximately 8:40 am EDT.

  • May 24, 2024

      Show headlines and story abstract

    • 4:15PM ET on Friday May 24, 2024 by PR Newswire
      Companies Mentioned: NVRO

      Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on May 7, 2024, the Compensation Committee of the Company's Board of Directors granted inducement restricted stock unit awards covering 59,460 shares of Nevro's common stock to twenty-six new non-executive employees to induce them to accept employment with Nevro. Each award was granted under the Nevro Corp. 2023 Inducement Award Plan and vests over a three-year period, subject to continued employment with Nevro through each vesting date.

    • 4:15PM ET on Friday May 24, 2024 by Dow Jones
      Companies Mentioned: NVRO

      Nevro Announces New Employee Inducement Grants Under NYSE Rule 303A.08

      PR Newswire

      REDWOOD CITY, Calif., May 24, 2024

      REDWOOD CITY, Calif., May 24, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, announced that on May 7, 2024, the Compensation Committee of the Company's Board of Directors granted inducement restricted stock unit awards covering 59,460 shares of Nevro's common stock to twenty-six new non-executive employees to induce them to accept employment with Nevro. Each award was granted under the Nevro Corp. 2023 Inducement Award Plan and vests over a three-year period, subject to continued employment with Nevro through each vesting date.

  • May 22, 2024

Peers Headlines